Begam, Howa and Nandi, Samit Kumar and Kundu, Biswanath and Chanda, Abhijit (2017) Strategies for delivering bone morphogenetic protein for bone healing. Materials Science & Engineering C-Materials for Biological Applications, 70 (1). pp. 856-869. ISSN 0928-4931

[img] PDF - Published Version
Restricted to Registered users only

Download (1452Kb) | Request a copy


Bone morphogenetic proteins (BMPs) are the most significant growth factors that belong to the Transforming Growth Factor Beta (TGF-beta) super-family. Though more than twenty members of this family have been identified so far in humans, Food and Drug Administration (FDA) approved two growth factors: BMP-2 and BMP-7 for treatments of spinal fusion and long-bone fractures with collagen carriers. Currently BMPs are clinically used in spinal fusion, oral and maxillofacial surgery and also in the repair of long bone defects. The efficiency of BMPs depends a lot on the selection of suitable carriers. At present, different types of carrier materials are used: natural and synthetic polymers, calcium phosphate and ceramic-polymer composite materials. Number of research articles has been published on the minute intricacies of the loading process and release kinetics of BMPs. Despite the significant evidence of its potential for bone healing demonstrated in animal models, future clinical investigations are needed to define dose, scaffold and route of administration. The efficacy and application of BMPs in various levels with a proper carrier and dose is yet to be established. The present article collates various aspects of success and limitation and identifies the prospects and challenges associated with the use of BMPs in orthopaedic surgery. (C) 2016 Elsevier B.V. All rights reserved.

Item Type: Article
Subjects: Engineering Materials
Divisions: Bioceramics & Coating
Depositing User: Bidhan Chaudhuri
Date Deposited: 19 Jan 2018 07:03
Last Modified: 19 Jan 2018 07:03

Actions (login required)

View Item View Item